New addition to the Asper Ophthalmics portfolio: Leber Hereditary Optic Neuropathy, testing three primary mutations in mtDNA.
Leber Hereditary Optic Neuropathy
Published 22/09/2011Leber Hereditary Optic Neuropathy
Targeted mutation analysis
Genes: | MT-ND1, MT-ND4, MT-ND6 |
Lab method: | Sanger sequencing |
No of detectable markers: |
3 (m.3460G>A, m.11778G>A, m.14484T>C) |
TAT: | 2-4 weeks |
Specimen requirements: | 2-4 ml of blood with anticoagulant EDTA
300 ng DNA in TE, AE or pure sterile water at 100-250 ng/µl |
Ordering information: | Go to online ordering or download sample submission form |
Mitochondrial genome sequencing
Lab method: | NGS Heteroplasmy less than 20% is not detectable by sequencing. |
TAT: | 2-4 weeks |
Specimen requirements: | 2-4 ml of blood with anticoagulant EDTA
1 µg DNA in TE, AE or pure sterile water at 100-250 ng/µl |
Ordering information: | Go to online ordering or download sample submission form |
Indications for genetic testing:
1. Confirmation of clinical diagnosis
2. Genetic counseling
Leber hereditary optic neuropathy (LHON) is characterized by optic nerve dysfunction that leads to painless, subacute loss of central vision. Disease affects mainly young adult males. LHON is caused by mutations in mtDNA and it is transmitted by maternal inheritance. Approximately 95% of individuals with LHON have one of three point mutations of mitochondrial DNA (m.3460G>A, m.11778G>A, or m.14484T>C).
The prevalence of LHON is estimated to 1:50 000. The m.11778G>A mutation accounts for about 90% of Asian cases and 50 to 70% of Caucasian cases. The m.14484T>C mutation occurs about 86% cases in Quebec, Canada. Frequency of the m.3460G>A mutation is about 20% in European LHON patients.